TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma
Clinical trial NCT03293784 · COMPLETED
Trial details
- NCT number
- NCT03293784
- Sponsor
- Institut Claudius Regaud
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-16
- Primary completion
- 2019-12-06
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.